A strong legal environment based on clear laws and regulations coupled with strict compliance is essential to fostering bioscience technology innovation and business growth. This means that intellectual property (IP) rights must be respected as a rule of law, and regulations must be in place to ensure the highest level of ethical standards by which companies conduct their governance, finances, operations and marketing.
MichBio advocates for:
Comprehensive and enforceable patents, copyrights, trademarks and other IP rights.
Recognition of IP rights internationally and prohibition of unfair, anti-competitive legal measures.
Modernization and improvement in the quality, predictability and timeliness of the U.S. patent system, full funding and efficient function of the U.S. Patent & Trademark Office (USPTO), and policies that incentivize technology transfer.
The curbing of abusive practices regarding patent infringement and litigation by non-practicing entities (NPEs) or so-called "patent trolls".
On other legal matters, like ethics of business practice, MichBio supports clear and transparent rules for engaging health providers in a reasonable manner without undue influence. Ethical interactions enhance patient access to the safe and effective
use of biomedical technologies through training partnerships. In addition, such interactions aid in ongoing product development through legitimate
and transparent collaborations that bring new life-changing products to patients.
Regulations & Decisions